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Neonatal isoimmune thrombocytopenic purpura accounts for 20% of cases of thrombocytopenia in the newborn. Two per cent of women are platelet antibody Al negative and therefore at risk of an affected pregnancy.
The disease has a mortality of 10-14% 1 and haemorrhagic complications are common. Intracerebral lesions are the main cause of mortality and serious morbidity. Perinatal haemorrhage is well recognised. More recently the prenatal development of such lesions has been documented. [2] [3] [4] [5] [6] We describe five children with neonatal isoimmune thrombocytopenic purpura and porencephaly as a result of prenatal intracerebral damage.
Case reports
Details of the five cases are shown in tables 1 and 2. All infants developed skin purpura shortly after delivery and were found to be severely thrombocytopenic. All had proved neonatal isoimmune thrombocytopenic purpura, and other causes of thrombocytopenia were excluded. Case 5 is of particular interest as the diagnosis of neonatal isoimmune thrombocytopenic purpura was made retrospectively when he was 10 years old. He had neonatal thrombocytopenia of unknown aetiology, and later presented with visual impairment. He had had the characteristic features described above, and we confirmed the diagnosis of neonatal isoimmune thrombocytopenic purpura serologically.
Discussion
The recognition that intracerebral lesions may occur prenatally in patients with neonatal isoimmune thrombocytopenic purpura has important implications for the further understanding of this condition and for the management of affected pregnancies. Though a number of such cases have now been reported there is no information regarding the incidence, mechanism, and neurological consequences of these lesions.
We have described five infants with neonatal isoimmune thrombocytopenic purpura and porencephaly resulting from prenatal damage. One had an intracranial haemorrhage in the immediate prenatal period. In the other four, severe neurological damage was the result of an intracerebral event that occurred earlier in pregnancy. These earlier lesions give rise to a characteristic pattern of neurological abnormality including optic hypoplasia, which has not previously been described in this disease. Interestingly, one previous case report of congenital porencephaly in two siblings with neonatal isoimmune thrombocytopenic purpura documents similar features, although they describe optic atrophy rather than optic hypoplasia.6 Examination of our patients clearly indicated that the optic nerves were hypoplastic rather than simply atrophic. Because the purpura is transient, neonatal isoimmune thrombocytopenic purpura may remain undiagnosed in the neonatal period. Some unexplained cases of porencephaly may therefore be the result of prenatal damage in neonatal isoimmune thrombocytopenic purpura (case 5). We looked at a further five children with unexplained porencephaly and carried out platelet typing of mother and child; in no case was there evidence of platelet incompatibility. Nevertheless, neonatal isoimmune thrombocytopenic purpura should be considered as a possible diagnosis in unexplained porencephaly, particularly if it is associated with optic hypoplasia.
In conclusion, prenatal intracerebral lesions occur in association with neonatal isoimmune thrombocytopenic purpura and give rise to a characteristic pattern of neurological abnormality, including optic hypoplasia. Further clarification of the mechanism of these lesions is required. 
